Status:

COMPLETED

Comparative Cardiovascular Effectiveness of GLP-1 RAs vs. Insulin in Early-Onset Type 2 Diabetes

Lead Sponsor:

Karolinska Institutet

Conditions:

Type 2 Diabetes Mellitus (T2DM)

Eligibility:

All Genders

18+ years

Brief Summary

The incidence of early-onset type 2 diabetes (T2D) is increasing globally. People with early-onset T2D have faster beta-cell deterioration and more aggressive diabetes progression than their late-onse...

Detailed Description

Yuxia Wei Introduction The incidence of T2D in adolescence and young adults is increasing alarmingly worldwide\[1\]. Early-onset (age at diagnosis \<40) T2D is more aggressive and has faster beta-cell...

Eligibility Criteria

Inclusion

  • We will include people diagnosed with T2D for more than 6 months and with metformin use within 6 months before the initiation of the treatment of interest (GLP-1 RA or insulin).

Exclusion

  • Individuals will be excluded if they meet one of the following criteria any time (unless stated otherwise) before or at treatment initiation: (1) other types of diabetes diagnosis recorded in NDR or NPR; (2) diagnosis of acute pancreatitis one month prior to treatment initiation; (3) diagnosis of other pancreatic diseases (chronic pancreatitis, cyst of pancreatis, etc; ICD-10 code K86) recorded in NPR; (4) use of GLP-1 RA or insulin within 1 year prior to treatment initiation, (5) advanced kidney disease (eGFR\<30 mL/min/1.73 m2, dialysis or kidney transplant \[procedure codes: KAS\[10\]\]); (6) end-stage liver disease (K70.4, K71.1, K72, Z94.4, procedure codes JJC); (7) cancer of the digestive system (ICD codes: C15-C26) or endocrine glands such as thyroid (ICD codes: C73-C75); (8) inflammatory bowel diseases (ICD-10 K50-K52)

Key Trial Info

Start Date :

January 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 31 2025

Estimated Enrollment :

92100 Patients enrolled

Trial Details

Trial ID

NCT06913881

Start Date

January 1 2010

End Date

January 31 2025

Last Update

April 6 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Karolinska Institutet, Institute of Environmental Medicine

Stockholm, Sweden, 171 77